November 20, 2017 - On Nov. 15, The Heart Hospital Baylor Plano completed its 1,000th transcatheter aortic valve replacement (TAVR) procedure. The Heart Hospital Baylor Plano was a pioneer in the development of TAVR. Read the article on the 1,000th TAVR procedure »
October 23, 2017 - Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, announced today that it will incorporate the HeartFlow® FFRct Analysis in a case series of robotic-assisted percutaneous coronary intervention (PCI) procedures with the
CorPath® GRX System to evaluate the feasibility and utility of clinical decision support.
Read the full article on the HeartFlow FFRct Analysis »
September 12, 2017 - Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, today announced first patient enrollment in the PRECISION GRX Registry, a post-market study to continue market surveillance of the Company's second generation CorPath® GRX System.
Read the full article on the GRX Registry »
August 8, 2017 - The Heart Hospital Baylor Plano performed their 50th
WATCHMAN™ procedure on Tuesday, August 8, 2017. Earlier this year, The Heart Hospital Baylor Plano was among the first hospitals in Dallas-Fort Worth to offer the WATCHMAN procedure as an alternative to long-term warfarin medication. This achievement represents significant growth of the Left Atrial Appendage Management Program.
Read the WATCHMAN article »
March 31, 2017 - As the largest cardiothoracic robotic surgery program in Texas, The Heart Hospital Baylor Plano has achieved what few hospitals worldwide have: 1,000 cardiothoracic procedures using minimally invasive robotic surgery.* This type of minimally invasive surgery allows for shorter hospital stays and fewer complications compared to the national average for traditional surgery.** That's the kind of surgical experience you can feel good about.
Read the full article on robotic surgeries »
*Based on volume data provided by Intuitive Surgical. **Based on Press Ganey® database scores for period 2007 through 2016.
Patients with peripheral artery disease can now be treated with new technology
March 24, 2017 - The Heart Hospital Baylor Plano announces the successful completion of the first robotic-assisted peripheral intervention in Texas on Feb. 13. The procedure has been performed using Corindus Vascular Robotics
CorPath System—the first and only Food and Drug Administration-cleared medical device used for robotic-assisted peripheral vascular interventions. These procedures involve placing stents in small arteries in intestines or legs to improve blood flow.
Read the full article on robotic-assisted peripheral intervention »
Enrollment begins on new clinical study for the first device designed specifically for the endovascular treatment of aortic arch and descending thoracic aorta lesions, while maintaining flow into a single aortic arch branch vessel.
March 3, 2017 - The Heart Hospital Baylor Plano is proud to be the only approved implant site in North Texas for the W.L. Gore & Associates, Inc. (Gore) GORE® TAG® Thoracic Branch Endoprosthesis (TBE) privotal study. William Brinkman, MD, medical director, Thoracic Aortic Disease Center, The Heart Hospital Baylor Plano is the principal investigator for the pivotal trial at this site.
Read the full article on the GORE TAG »
Image courtesy of W.L. Gore & Associates, Inc.
The Heart Hospital Baylor Plano is among the first hospitals in Dallas-Fort Worth to offer patients with non-valvular atrial fibrillation (AF) an alternative to long-term warfarin medication with the newly approved WATCHMAN Left Atrial Appendage Closure (LAAC) Implant
February 16, 2017 - For patients with AF who are considered suitable for warfarin by their physicians but who have reason to seek a non-drug alternative, the
WATCHMAN LAAC Implant is an implant alternative to reduce their risk of AF-related
WATCHMAN Implant closes off an area of the heart called the left atrial appendage (LAA) to keep harmful blood clots from the LAA from entering the blood stream and potentially causing a stroke. By closing off the LAA, the risk of stroke may be reduced and, over time, patients may be able to stop taking warfarin.
Read the full article on the WATCHMAN »
February 15, 2017 - The Heart Hospital Baylor Plano is one of only 42 of 317 eligible health care facilities in the United States to receive 3 Stars — the highest score possible — during the Society of Vascular Surgery's 2016 Vascular Quality Initiative (VQI) Participation Awards. It is the second consecutive year THHBP has received the 3 Star honor, which recognizes the importance of tracking and reporting outcomes of patients who have had vascular procedures.
Read the full article on vascular care »
New technology gives detailed look inside the heart for treatment of irregular heartbeat
February 10, 2017 - The Heart Hospital Baylor Plano is the first North Texas hospital to use the St. Jude Medical™ EnSite Precision™ cardiac mapping system, a next generation technology that helps physicians diagnose arrhythmias, or irregular heartbeats, and determine the best treatment options.
Read the full article on the cardiac mapping system »
Image courtesy of: St. Jude Medical™ EnSite Precision™
Patients with coronary artery disease can now be treated with new robotic-assisted technology
January 19, 2017 – The Heart Hospital Baylor Plano today announced the successful completion of the first robotic-assisted coronary angioplasty in the Dallas/Fort Worth region. The procedure has been performed using Corindus Vascular Robotics
CorPath System—the first and only FDA-cleared medical device to bring robotic-assisted precision to coronary angioplasty procedures.
Read the full article on robotic-assisted angioplasty »
Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, The Heart Hospital Baylor Plano or Baylor Health Care System.